INTRODUCTION
Refractive surgery in children is controversial. Most children with refractive errors can be treated adequately and safely with spectacles or contact lenses, along with conventional therapy for amblyopia. However, in specific subpopulations of children, intervention may be necessary to achieve full visual function and prevent amblyopia. Procedures employed in pediatric refractive surgery include laser keratorefractive procedures and intraocular procedures such as phakic intraocular lens (pIOL) implantation or clear lens extraction. There is an abundance of literature demonstrating the efficacy and safety of pIOLs in the adult population [1, 2] . In children, however, there is less evidence to support their use. This article aims to review the evidence for pIOLs in the treatment of high-refractive errors and amblyopia in the pediatric population.
Indication for pIOLs in Children
Most children with refractive errors can be treated adequately and safely with spectacles or contact lenses, along with conventional therapy for amblyopia. However, in certain subsets of children, traditional treatment is ineffective and further intervention is necessary. Currently, refractive surgery in children is performed only when conventional treatments have failed. In children with high-refractive errors, spectacle tolerance can be reduced secondary to prismatic induced aberrations, limited field of view, as well as cosmetic appearance. Contact lenses can also be problematic in children due to difficulty with insertion and removal, infection, intolerance and expense.
The particular pediatric subpopulations that may require refractive surgery include those with bilateral significant ametropia or anisometropia who are spectacle or contact lens noncompliant, as well as those with secondary high-refractive amblyopia in children with neurobehavioral disorders (Table 1) .
pIOL Implants pIOLs are available in three models, iris-fixated anterior chamber, ciliary sulcus-supported posterior chamber, or angle-supported anterior chamber. The preference currently appears to be for iris-fixated anterior chamber IOLs [3] . The first pIOL implanted in a child was carried out in 1998 by Lesueur and Arne [4] , a posterior chamber pIOL (PC-pIOL) was successfully implanted in five children (aged 3-16 years) with high anisometropic myopia who were noncompliant with spectacles or contact lenses. Following the positive outcome of this study, further studies were undertaken using both anterior and PC-pIOLs to restore emmetropia [3] [4] [5] [9] [10] [11] [12] [13] [14] [15] , with the aim of treating refractive-induced amblyopia.
PC-pIOL
Lesueur and Arne [4] reported results of PC-pIOL insertion in five eyes of children aged 3-16 years old with amblyopic high myopia and a mean preoperative spherical equivalent of -12.8 D. There were no complications reported from the study, and all parents reported an improvement in their child's quality of life.
A gain of 3 or more Snellen lines, as well as recovery of binocular vision was observed in two patients. A follow-up study by Lesueur and BenEzra et al. [6] implanted PC-pIOLs in three children (aged 9-18 years) with anisometropic amblyopia and myopia of -6 to -16 D. Follow-up over a 9-month period showed significant improvement in visual acuity and binocular function. No change in endothelial cell count was observed over the 9-month follow-up period.
Alio et al. report the longest follow-up period of 5 years, following PC-pIOL implantation in a child with high anisometropic amblyopia. Improvement in visual acuity of one logMAR line was reported, and no complications were seen [7] .
Potential complications of PC-pIOLs include cataract formation, pupillary block glaucoma, posterior dislocation into the vitreous cavity, and retinal detachment [8] . Reports of complications in the pediatric population are rare; however, this is likely due to the low overall numbers of PC-pIOLs in children.
Anterior Chamber Iris-Claw pIOL
The iris-claw anterior chamber IOL, designed by Jan Worst, was first implanted in the adult population in 1978 to correct aphakia following cataract surgery. In 1986, this design was altered to a biconcave polymethyl-methacrylate optic with an overall length of 8.5 mm, and the IOL was implanted in the first sighted myopic eye [9] . The design was further modified in 1991 to a convex-concave IOL, and in 1998, the name to correct aphakia in a series of 27 children (38 eyes) [10] . The advantages of pIOLs are numerous (Table 3) . With pIOLs, the surgeon is capable of treating a much larger range of refractive errors than can be safely treated with corneal refractive surgery, and natural accommodation is preserved. The skills required for insertion are Table 3 Advantages of phakic intraocular lenses [18, 19] . LASIK is technically difficult in children, requires general anesthesia, and has the risk of long-term ectasia. Traumatically induced displacement of a LASIK flap is a serious and sight-threatening complication, which children are inherently at high risk of given the nature of children's behavior and activities. Refractive lens exchange results in an increased risk of retinal detachment, glaucoma, and posterior capsule opacification, as well as loss of accommodation [20] .
The implant of choice for pediatric patients is the anterior chamber Artisan iris-fixated pIOL (Figs. 1, 2) , although the foldable Artiflex model which requires a smaller incision and less corneal sutures has been shown to be safe and effective also [17] . Safe insertion and lower long-term risk for endothelial cell loss requires an anterior chamber depth of 3.2 mm or greater. This may preclude the use of irisfixated pIOLs in children younger than 3 years, and children with shallow anterior chambers, as can occur in children with high myopia following retinopathy of prematurity. Reports of adverse events in the pediatric population are rare due to the limited number of surgeries performed; however, complications in adults include cataract formation, uveitis, IOL dislocation, pigment dispersion, and 
